Every year, thousands of French women cross the border to do something their own country will not let them do: get pregnant. The most famous woman in France is about to join them. The real question is not why she’s leaving. It’s why there are so many just like her.
She has hung in the museum since 1797. Close to nine million people a year file past her. She has survived a theft in 1911, a rock thrown at her in 1956 and a cup of soup in 2024 as well as two centuries under French protection.
And now she’s leaving.
In our new campaign film, the Mona Lisa steps out of her frame, walks past the guards, out of the museum, and heads south. Destination: a fertility clinic in Spain. The reason: she wants a baby, and France can’t help her in time.
It’s a joke, of course. But every joke needs a kernel of truth. And this one has a very large kernel.
Because the woman in the frame is not really the Mona Lisa. She is the 45-year-old who wrote to a clinic in Spain this autumn: “I still have my periods, but in France I’m considered too old to be allowed to have IVF”. She is the woman of 42 who wrote, with her partner, that after three ICSI attempts in France that “the embryos never held”. She is the woman of 43, five years into a solo fertility journey in a French public centre, two embryos left and one miscarriage behind her, who wrote “I’d like to turn to [a clinic] abroad” and sent a message to seventeen clinics in one evening. She is the couple of 45 and 47 whose own gynaecologist advised them “to contact Spain or Portugal”, and who already had two Spanish quotes in hand when they wrote to us. All four are real patients who contacted clinics through our platforms this year; we have removed anything that could identify them [4].
She has a different face in every French town, and she is leaving in numbers that, to our knowledge, no French institution measures.
So the question this campaign asks is not “why is the Mona Lisa leaving?” It’s a harder one.
Why are there so many Mona Lisas in France?
How many Mona Lisas are there?
Let’s start with what we know for certain.
France performs a lot of fertility treatments. According to the Agence de la biomédecine, the public body that oversees it, there were 171,942 assisted reproduction attempts in 2024 and close to 28,850 children born as a result, 4.4% of all French births. About one child in 23 [1].
And yet, every year, thousands of French patients leave. Not for a holiday. For a treatment.
The scale is hard to pin down, because, to our knowledge, no French institution publishes any hard numbers. Spain does, more or less. Spain’s national registry recorded 168,372 IVF cycles in 2023, and around one baby in five born from treatment in Spanish clinics that year was born abroad, to a patient who had travelled to Spain[2]. Of those foreign patients, French women have long been the single biggest group. In 2023 they accounted for 38.3% of the IVF-ICSI cycles performed on non-resident patients, far ahead of Italians (19.2%) and Britons (8.1%) [2]. In 2021, the French-language press in Barcelona reported that nearly half the patients of the city’s specialised fertility centres were French [3].
A gynaecologist at a clinic in Alicante put it bluntly at the time: 99% of her French patients, “if not 100%”, had already done one or more cycles in France before they came [3].
So these are not simply impulsive tourists. They are patients who tried the French system first. Who were turned away, or timed out, or wore out. And then packed a bag. Every one of them is a Mona Lisa.
What we hear from them is the same story, told in a thousand variations. We can see it in our own records, which we’re publishing here for the first time [4]. Between 1 January and 18 October 2026, 601 patients living in France contacted clinics abroad through our platforms, sending 1,833 inquiries between them. About three per patient. That is one in seven of every inquiry we handled this year, from any country. France was our second-largest source of patients in the world, behind only the UK, a country where most IVF is privately funded, and ahead of the United States. Two in three of those inquiries went to Spain. One in six to Greece. The rest to the Czech Republic, North Cyprus, Latvia, Portugal and Denmark.
Four figures from those inquiries tell the story better than we can.
Nearly half of them, 46%, were for IVF with donor eggs. Two-thirds came from women aged 43 or over, the age from which French law no longer allows egg retrieval, and therefore IVF with your own eggs. Almost half came from women aged 46 or more. And more than one inquiry in three declared at least one failed cycle, most of them in France; around 300 declared three or more failed IVF cycles.
Their messages, which are quoted here anonymised and lightly edited, read like a single long letter.
“My doctor in France is talking about IVF abroad because PGT-A isn’t allowed here.”
“After six IVF attempts in France without a pregnancy, we were advised to try donor eggs.”
“Two ICSI attempts without implantation, and we were shown the door, with the explanation that the problem was probably my eggs.”
“My husband turns 60 in December. In France that’s the end for him, so we want to continue abroad.”
“Our gynaecologist advised us to contact Spain or Portugal.”
That last one deserves a pause. Some French doctors are now, quietly, referring their own patients out of the country.
So, why so many? As far as we can tell, there are four reasons which come up frequently.
Reason one: the clock
French law is precise about age. Since the introduction of the 2021 bioethics law and its implementing decree, a woman can have eggs retrieved until her 43rd birthday, and be inseminated or have an embryo transferred until her 45th birthday. The partner who will not carry the child must be under 60 [5]. These are not reimbursement rules. They are legal conditions: after that, treatment in France is no longer permitted, whether the patient opts to pay for it herself or not.
43 sounds reasonable until you look at who actually walks into a fertility clinic. The average French mother is now over 31 when she gives birth (31.2 in 2025), according to the national statistics office [6]. Many start trying in their late thirties. By the time the tests are done, the referrals made, the first failed cycle absorbed, the second one scheduled, she is 41. Then 42. Then the letter arrives.
IVF Abroad - Patient's Guide 2026
IVF Costs, Success Rates and Laws in 11 Countries Compared + Country Popularity Report.
In Spain there is no legal upper age limit; the medical council recommends not treating beyond 49 years and 11 months, and the vast majority of clinics follow that line [3]. In Greece the legal limit was raised to 54 in 2022, with prior authorisation required above 50. In the Czech Republic it is 49 [7].
Is 43 the right number? Maybe. Egg quality does fall sharply after 40, and nobody serious disputes that. But with donor eggs the picture changes: success depends mainly on the donor’s age, not the recipient’s, and stays broadly stable until the recipient’s late forties, according to a study presented at the ESHRE congress in 2026. European registry data put the clinical pregnancy rate per fresh donor-egg embryo transfer at 53% [8]. The biology says one thing. The law says another.
Reason two: the wait
Here is the number that explains more than any other.
In 2025, a woman in France who needed donor eggs waited, on average, 22 months. Almost two years. More than 2,700 people were on that list at the end of 2025. The number of women who came forward to donate was 1,050, up from 929 the year before. The Agence de la biomédecine presented it as progress: it was the first time the count had passed one thousand [9].
Do the arithmetic. More than 2,700 waiting. 1,050 donors. One donation does not equal one recipient. And a 41-year-old waiting two years becomes a 43-year-old: the age at which health-insurance cover stops. At 45, any embryo transfer becomes illegal [5]. The list quietly pushes people past those limits while they are still on it.
For donor sperm, it is the same picture, only bigger. 17.7 months on average, 8,700 people waiting at the end of 2025, and more than 12,000 new requests in a single year, a demand that surged when single women and female couples who were finally allowed to apply in 2021 discovered the queue [9].
In Spain, patients consistently report that the wait for a donor is minimal: the patients and clinics we work with speak of weeks rather than years.
Why such a gap? Partly because Spain compensates donors, around €1,000 per donation according to donors and clinics interviewed by the French press, while France refuses to, standing by the principle that donation must be free [2]. Partly because Spain has around 250 IVF centres competing to recruit donors [2], while French law reserves donations to public or private non-profit establishments: 36 centres did egg donation in 2023, and they have to run it alongside everything else they do [10]. That is a choice. France chose it, for ethical reasons that many people share. But every choice has a bill, and this one is paid by the women on the list.
Reason three: what you’re not allowed to ask for
Then there is the list of things that simply don’t exist in France.
PGT-A. Testing an embryo for the right number of chromosomes before transfer. When a patient is over the age of 40, more than half of embryos carry a chromosomal abnormality, according to the authors of a bill filed in the National Assembly [12]. Spain and several other European countries allow the test. France bans it. The authorisation of a French clinical trial was annulled by the Montreuil administrative court in 2024, a decision upheld during its appeal in 2025; in June 2026 Parliament’s joint science office, the OPECST, recommended authorising the test at least experimentally [11]. A bill to legalise it was filed on 13 October 2026. Co-drafted with the patient collective BAMP!, it is backed by deputies from seven political groups, from Les Républicains to the Communists. Its author, Constance de Pélichy, herself admits that adoption remains very uncertain [12].
The ROPA method, where one woman in a female couple provides the egg and the other carries the pregnancy. Legal in Spain. Not permitted in France: the law does not expressly forbid it, but the Conseil d’État ruled in 2024 that it is incompatible with the principle of anonymous egg donation [3].
Knowing something more about your donor. In France, the medical team chooses the donor, and you have access to the profile. In Spain, donation is anonymous too, but you can obtain general information, such as the donor’s age or blood group, and the law requires the medical team to seek the closest possible physical resemblance to the recipient [3].
Egg freezing on your own terms. France opened social egg freezing in 2021, between 29 and 37, almost only in non-profit centres. More than 20,700 requests for a first appointment were recorded in 2025, and the average wait that year was 11.7 months. 54% of requests are concentrated in the Paris region [9]. In December 2025 a deputy told the National Assembly that the Agence de la biomédecine had counted more than 20,000 requests with only 4,000 cases taken on, with waits of two years being reported in many centres [13]. The window closes at 37 whether you receive your appointment or not.
Four attempts. The health insurance covers four IVF cycles, generously, at 100% [5]. The fifth is at your own expense, and patients tell us that in practice most public centres refuse to do it anyway. After four failures, those who want to try again hit a wall.
Reason four: the belief that it works better elsewhere
This is the one nobody in the French system likes to talk about.
Many patients leave because they believe their chances are better abroad. Are they?
It is hard to say, and anyone who gives you a clear answer is probably selling something. In reality, the figures published from one country to the next cannot be compared: they rest on neither the same indicators, nor the same patients, nor the same treatments. France’s agency publishes a cumulative delivery rate per egg retrieval of 30%, a perfectly respectable result [14]. Spain’s registry breaks its results down by treatment type (own or donor eggs, fresh or frozen, with or without PGT-A) without stating an overall figure. So the numbers do not measure the same thing, and nothing allows anyone to claim that success is higher abroad.
But patients don’t read registries. They read outcomes. And a few things are objectively true:
- Donor eggs from a 25-year-old give better odds than own eggs at 41. Spain gives you the donor egg in weeks. France gives it to you in two years, if at all.
- In Spain, roughly one baby in ten is born after fertility treatment (2023 figures), versus about one in 23 in France (2024), according to the two countries’ registries [1][2]. Relative to its population, Spain does far more of it, and volume builds expertise.
- Private Spanish clinics run on patient outcomes, because that is how they get the next patient. A public French hospital runs on a budget, a queue and a law. That is our take on it, not a statistic.
So “better success rates abroad” is part myth, part reality, and partly a side effect of being allowed to use the right treatment at the right time. Which brings us to the uncomfortable part.
What patients told us
In 2024 we surveyed 1,189 patients who were researching IVF abroad. 65 of them were French [15]. Here is what made France different.
For British, Irish, American and Canadian patients, the number one reason to leave home was money. For the French, money was not even second. Legislation was named 34 times. Cost, 16 times, behind availability of treatment and quality of care. Law over money, more than two to one.
Lost in clinic options? Talk to our IVF advisor.
We’ll help you find trusted IVF clinics abroad - tailored to your medical needs, budget, and treatment goals.
Put differently: French patients are not fleeing the price of French IVF. French IVF is essentially free, with four attempts covered at 100% [5]. They are fleeing its rules.
Other things we learned about the French respondents:
- 63% had already done at least one IVF cycle before looking abroad.
- Donor eggs were by far the most sought treatment, named almost twice as often as own-egg IVF.
- Spain was shortlisted by 72%, Portugal by 37%, the Czech Republic by 35%, Greece and Denmark by 34% each.
- 42% did not want to spend more than €5,000: no other country in the survey had this many small budgets. For people used to having their healthcare largely reimbursed, paying upends every reference point.
- Only 22% were interested in multi-cycle refund packages, the lowest of any nationality. The French patient is not shopping for insurance. She wants one treatment that works and quickly.
Why we made a painting walk
We want to be honest about what this campaign is and isn’t.
We help patients find clinics abroad. That is our business. We could run an ordinary advert: sun, beach, happy baby, “book now.”
We didn’t want to. Because the truth is that IVF abroad is not the ideal solution. It is the workaround.
IVF is one of the hardest things a person can go through. Daily injections. Blood tests every two days. A retrieval under sedation. The two-week wait. A phone call that can end everything. Doing that at home, with your own doctor, in your own language, with your partner in the next room and your mother a train ride away, is better. It is medically better, because monitoring is simpler and the continuity of care is real. It is emotionally better, for reasons that don’t need explaining to anyone who has done it.
Doing it in a hotel room in Alicante, with a translator on WhatsApp and a flight home the morning after transfer, is what people do when the first option has been taken away from them. We hear this from patients every week.
So, the Mona Lisa didn’t leave France because Spain is wonderful. She left because the building she’s in won’t let her do what she needs to do. She is Italian, after all, painted by a man who died in France, and she has spent more than 500 years in the care of the French state. If even she has to go, what reason is there to stick around?
And if one painting walking out of a museum is a story, what are thousands of women walking out of a health system?
That’s the question we want the French fertility world to sit with. Not “how do we stop patients leaving?” Because you can’t, and you shouldn’t. But “why do they want to?”
The open questions
We don’t have all the answers. We’re not sure anyone does. But these are the questions we think deserve a public answer:
Why does a system that pays 100% for four cycles accept a two-year wait for the one ingredient many of those cycles need? Reimbursement is not access. A free treatment you cannot get is not free.
Is 43 a medical limit or a budgetary one? If it’s medical, why does the transfer limit sit at 45? If it’s budgetary, say so, and let women over 43 pay for treatment at home instead of paying for it abroad.
Why can a French embryo be tested for a serious hereditary disease but not for the one thing most likely to stop it implanting? The evidence on whether testing improves the chance of a baby is mixed, which is exactly why a trial matters. The PGT-A debate has run since the 2019 bioethics debates. A trial was authorised in 2021, then annulled [11]. The data France says it needs is, as far as we can tell, being generated in Spain, on French patients, every week.
Who is counting? Spain knows roughly how many foreign patients it treats. To our knowledge, France publishes no figure for how many of its citizens leave for treatment, how much they spend, or what happens to them. You cannot fix what you refuse to measure.
What happens in 2028? That is the date the government has announced for the next revision of the bioethics law [13]. The last one, in 2021, opened treatment to single women and female couples; the donor shortage that followed is documented in the agency’s own figures [9]. The one before, in 2011, kept the door closed to single women for another decade. Patients have heard “next time” before.
The last word
France does not lack assets. Its fertility teams are well regarded. It has coverage that patients in London or New York would envy. It has 108 authorised IVF centres [1], a national registry, and, in our experience, a public that broadly supports the idea that everyone who wants a child should get help.
What it doesn’t have is enough donors, enough time, enough flexibility, or enough honesty about the gap between what the law promises and what the clinics can deliver.
Until that changes, the trains to Barcelona will stay full. There will still be too many Mona Lisas in France. And a certain Florentine woman with an unreadable smile will keep walking out the door.
We’ll be happy when we can tell her, and all the others, that they can go home.
This essay accompanies the “Mona Lisa” campaign, produced for French patients researching fertility treatment abroad. Figures are sourced below. Where a statement rests on what patients and clinics tell us rather than on published data, we say so in the text.
Sources
- Agence de la biomédecine, Rapport médical et scientifique 2024: https://rams.agence-biomedecine.fr/2024/amp-dpi/principaux-chiffres-de-l-activite and https://rams.agence-biomedecine.fr/2024/amp-dpi/don-d-ovocytes
- Sociedad Española de Fertilidad and Ministerio de Sanidad, Registro Nacional de Actividad 2023 (Registro SEF, full report: https://www.registrosef.com/public/docs/sef2023_IAFIV.pdf) and press note of 17 December 2025: https://sefertilidad.net/documentos/lyOlT-rkPKvRdGKY_wA1sINHS7Btlw189LVFTlHd5eE.pdf ; Made in Perpignan, “Enquête. Marché de la PMA en Espagne”, 23 June 2026: https://madeinperpignan.com/enquete-marche-pma-espagne-cliniques-achetent-ovocytes-femmes-francaises/
- Lepetitjournal.com Barcelone, “PMA : pourquoi les Françaises choisissent l’Espagne ?”, 12 September 2021, updated 11 January 2022: https://lepetitjournal.com/barcelone/sante/procreation-medicalement-assistee-pma-pourquoi-francaises-espagne-320114 ; ROPA not authorised in France: Conseil d’État, 19 June 2024, n° 472649: https://www.conseil-etat.fr/fr/arianeweb/CE/analyse/2024-06-19/472649 ; ROPA in Spain: Ley 14/2006, art. 7.3 (added by Ley 3/2007); physical resemblance between donor and recipient: Ley 14/2006, art. 6.5: https://www.boe.es/buscar/act.php?id=BOE-A-2006-9292
- IVF Media Leads Manager, inquiries from patients resident in France to partner clinics abroad, 1 January to 18 October 2026: internal data, available to journalists on request. Patient quotes are translated from French and anonymised.
- Service-public.gouv.fr, “Assistance médicale à la procréation (AMP)”, fiche F31462: https://www.service-public.gouv.fr/particuliers/vosdroits/F31462 ; Code de la santé publique, art. R. 2141-36 et seq., as set by décret n° 2021-1243 of 28 September 2021 implementing loi n° 2021-1017 of 2 August 2021; Assurance Maladie: https://www.ameli.fr/assure/sante/devenir-parent/concevoir-un-enfant/procreation-medicalement-assistee-pma-amp
- Insee, “Bilan démographique 2025”, Insee Première n° 2087, January 2026: https://www.insee.fr/fr/statistiques/fichier/8719824/ip2087.pdf
- Greece: Law 4958/2022 (Government Gazette A’ 142, 21 July 2022), article 3, amending article 4(1) of Law 3305/2005: https://www.taxheaven.gr/law/4958/2022/arthro/3 ; Czech Republic: Act No. 373/2011 Sb., § 6(1): https://www.dauc.cz/predpisy/331/373-2011-sb
- ESHRE, “ART in Europe 2021”, results presented at the ESHRE annual meeting, 9 July 2024: https://www.focusonreproduction.eu/press-releases/ivf-and-iui-treatment-cycles-increase-across-europe-along-with-stable-pregnancy-rates/ ; IVIRMA, study presented at the ESHRE annual meeting, July 2026: https://www.news-medical.net/news/20260705/Uterine-aging-may-reduce-donor-egg-pregnancy-success-after-49.aspx
- Agence de la biomédecine, press release “Publication des derniers résultats d’activité nationale en AMP : un niveau toujours élevé en 2025”, 14 April 2026: https://www.agence-biomedecine.fr/fr/assistance-medicale-a-la-procreation/publication-des-derniers-resultats-d-activite-nationale-en-amp-un-niveau-toujours-eleve-en-2025 ; Agence de la biomédecine, “Don de gamètes : cinq ans après la loi de bioéthique”, 9 September 2026: https://www.agence-biomedecine.fr/fr/don-de-gametes-et-assistance-medicale-a-la-procreation/don-de-gametes-cinq-ans-apres-la-loi-de-bioethique-une-adhesion-des-francais-qui-se-confirme ; Agence de la biomédecine, press release of 2 July 2024: https://www.agence-biomedecine.fr/fr/don-de-gametes-et-assistance-medicale-a-la-procreation/l-agence-de-la-biomedecine-a-besoin-de-doubler-le-nombre-de-donneurs-pour-faire-face-a-une-demande-qui-ne-faiblit-pas
- Office parlementaire d’évaluation des choix scientifiques et technologiques (OPECST), “Évaluation de l’application de la loi n° 2021-1017 du 2 août 2021 relative à la bioéthique”, Sénat rapport n° 798 (2025-2026) / Assemblée nationale rapport n° 2988, 25 June 2026, AMP section: https://www.senat.fr/rap/r25-798/r25-79821.html
- Same OPECST report, DPI-A section: https://www.senat.fr/rap/r25-798/r25-79846.html
- Assemblée nationale, proposition de loi n° 3314 “visant à autoriser le diagnostic préimplantatoire des aneuploïdies”, filed 13 October 2026 by eight deputies from seven groups, on the initiative of Constance de Pélichy: https://www.assemblee-nationale.fr/dyn/17/textes/l17b3314_proposition-loi ; Les Nouveaux Parents, “DPI-A : une proposition de loi déposée pour autoriser ce dépistage embryonnaire en France”, 15 October 2026: https://www.lesnouveauxparents.com/dpi-a-une-proposition-de-loi-deposee-pour-autoriser-ce-depistage/
- Assemblée nationale, question orale sans débat n° 465, Nathalie Oziol, JO 2 December 2025, and government answer, JO 10 December 2025: https://questions.assemblee-nationale.fr/dyn/17/questions/QANR5L17QOSD465.pdf ; Assemblée nationale, commission des affaires sociales, compte rendu n° 93, 24 June 2026: https://www.assemblee-nationale.fr/dyn/opendata/CRCANR5L17S2026PO420120N093.html
- Agence de la biomédecine, “Évaluation des résultats des centres d’AMP – FIV 2021-2022”, national report: https://back.agence-biomedecine.fr/uploads/National_Complet_FIV_2021_2022_ee480caac2.pdf ; Sociedad Española de Fertilidad, Registro SEF 2023, full report: https://www.registrosef.com/public/docs/sef2023_IAFIV.pdf
- IVF Media, “Seeking IVF Treatment Abroad – Patient Research 2024”, survey of 1,189 patients, fieldwork 6 January to 27 June 2024. Summary: https://www.ivfmedia.org/ivf-abroad-patient-research/ ; full report on request: https://www.ivfmedia.org/ivf-abroad-research-2024/








